A detailed history of Argyle Capital Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Argyle Capital Partners, LLC holds 5,598 shares of DHR stock, worth $1.19 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
5,598
Previous 4,098 36.6%
Holding current value
$1.19 Million
Previous $840 Million 31.63%
% of portfolio
0.91%
Previous 0.72%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$174.64 - $205.16 $261,959 - $307,740
1,500 Added 36.6%
5,598 $1.11 Billion
Q4 2024

Aug 13, 2025

BUY
$226.16 - $274.52 $926,803 - $1.12 Million
4,098 New
4,098 $941 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $154B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Argyle Capital Partners, LLC Portfolio

Follow Argyle Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argyle Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argyle Capital Partners, LLC with notifications on news.